
    
      This is a randomized, controlled, multi-center clinical study. The total study duration for
      each patient should be 12 ± 1 months.

      Straumann Bone Level implants will be placed in the pre-molar or anterior region of the
      mandible or maxilla for single tooth replacement, followed by provisional prosthetic loading
      after 25 ± 4 days and by final prosthetic loading 6 ± 1 months after implant loading.

      In total 6 visits per patient are scheduled in this study. Bone level changes, implant
      success and survival, gingival recession, subject satisfaction and adverse events (AEs) will
      be assessed.

      The study devices are CE-(Conformité Européenne, meaning European Conformity) marked
      products. Straumann Bone Level implants Ø 3.3 mm NC SLActive Roxolid and Straumann Bone Level
      Ø 4.1 mm RC SLActive implants.

      Five centers in USA will participate.
    
  